共 32 条
[1]
Wafa HA(2020)Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years Stroke 51 2418-2427
[2]
Wolfe CDA(1995)Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581-1587
[3]
Emmett E(2009)Thrombolysis for acute ischaemic stroke Cochrane Database Syst Rev 4 CD000213-2363
[4]
Wardlaw JM(2012)The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial Lancet 379 2352-3251
[5]
Murray V(2012)Intravenous thrombolytic treatment in the oldest old Stroke Res Treat 2012 923676-88
[6]
Berge E(2009)National Institutes of Health Stroke Scale certification is reliable across multiple venues Stroke 40 2507-287
[7]
Sandercock P(2014)Stroke in centenarians Geriatr Gerontol Int 14 84-256
[8]
Wardlaw JM(2002)Centenarian stroke treated with tissue-type plasminogen activator Cerebrovasc Dis 13 285-717
[9]
Lindley RI(2018)Outcomes of nonagenarians with acute ischemic stroke treated with intravenous thrombolytics J Stroke Cerebrovasc Dis 27 246-1935
[10]
García-Caldentey J(2011)Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age J Neurol Neurosurg Psychiatry 82 712-507